Log In
|
Sign Up
Analytics Tools
Stock Screener
Strategy Backtester
Stock Quote
Stock Chart
Watch Lists
Portfolio Tracker
Trade Alert
Crypto Screener
Crypto Backtest
Correlation
Quick Screens
Moving Averages
Oscillators
Trend Indicators
Line Studies
Chart Patterns
Channels
Volatility
Relative Strength
Financial Strength
Ichimoku
Price Action
Volume
Fundamental Data
Financial Metrics
To Industry Ratios
Dividend
In the Spotlight
Market Breadth
Cryptocurrency
Fund Screens
Intrinsic Value
Earnings Growth
Solid Dividends
Dogs of the Dow
Growth Leaders
Help
Help Topics
FAQ
What's New
Education
Articles
Contact Us
Get
Axsome Therapeutics Inc
MIL • Healthcare • Biotechnology • Quote as of 06/22/2026
Company Profile
Industry
Biotechnology
Sector
Healthcare
Exchange
MIL
Market Capitalization
11,115 mln
Float
43.56 mln
Earnings Date
08/04/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.77
Likely reliable
Relative Strength
79
/ 100
Strongly outperforming
Debt / Equity
4.03
Highly leveraged
ROE
-272
Deeply negative
Dividend Yield
0.00%
No dividend
Key Fundamentals
EPS
-3.26
ROE
-272
RPS
12.08
ROIC
-88.31
ROA
-28.10
EBITDA, mln
-150
EV / EBITDA
-68.78
EV / EBIT
-65.30
Revenue, mln
609
EV / Revenue
16.92
Financial Strength
Altman Z-Score
8.73
Piotroski F-Score
5
/ 9
Beneish M-Score
-2.77
Price Performance & Relative Strength
Period
Price Performance
Relative Strength
1 Week
7.66%
92
/ 100
1 Month
46.54%
98
/ 100
Disclaimer
-
Privacy Policy
-
Terms Of Service
-
Cookie Use Policy
-
FAQ
-
Contact Us
